Objectives: To decipher the mechanisms and their associated genetic determinants responsible for b-lactam resistance in a Proteus mirabilis clinical isolate.
Introduction
While decreased susceptibility to imipenem is intrinsic in Proteeae, some Proteus mirabilis exhibit an increased level of resistance to imipenem (with MICs ranging from 16 to 64 mg/L) due to loss of outer membrane porin, decreased expression of PBP1a or reduced binding of imipenem by PBP2. 1 The emergence of MDR P. mirabilis isolates producing acquired ESBLs, AmpC and carbapenemases has also been described. 2 The carbapenemases identified previously in P. mirabilis are the Ambler class A b-lactamase KPC-2, 3 the class B [metallo-b-lactamases (MBLs)] VIM-1 and NDM-1, 4 and the carbapenem-hydrolysing class D b-lactamase OXA-23. 5 The bla NDM-1 gene, firstly identified from a Klebsiella pneumoniae isolate, has been described in most enterobacterial species, but also in Vibrio cholerae, Pseudomonas spp. and Acinetobacter spp. 6 In Enterobacteriaceae, the bla NDM-1 gene is most often located on plasmids. 7 Plasmid acquisition occurs by conjugation or mobilization in Enterobacteriaceae; nevertheless, integrative mobilizable elements have been described in Salmonella spp., e.g. Salmonella genomic island 1 (SGI1). 8 The SGIs may contain MDR regions with genes encoding b-lactamases (e.g. ESBLs) and resistance to quinolones (Qnr), chloramphenicol/florfenicol, tetracycline and aminoglycosides. Variants of SGI1 have been classified from SGI1-A to SGI1-V, corresponding to variants of the MDR region. 9 -13 The integration of SGI1 into the chromosome of Salmonella spp. occurs at the last 18 bp of the 3 ′ -end of the thdF gene. 8 Since this conserved integration site has been also identified in diverse bacteria, it was hypothesized that P. mirabilis could be an acceptor of SGI independently of Salmonella spp., although SGI1 have been exceptionally detected in P. mirabilis isolates. 9 -14 Recently a new resistance genomic island belonging to the same family as SGI1 and named PGI1 (Proteus genomic island 1) has been described in P. mirabilis.
We describe here the co-occurrence of the carbapenemase gene bla NDM-1 together with the ESBL gene bla VEB-6 in a new SGI1 variant from a clinical P. mirabilis isolate.
Materials and methods
Bacterial strains and antibiotic susceptibility testing P. mirabilis PEL was isolated from a urine sample recovered from a patient hospitalized at Chambery hospital in France in 2012. P. mirabilis PEL was identified using the API 20E system (bioMé rieux, La Balme les Grottes, France). Escherichia coli TOP10 (Life Technologies, Cergy-Pontoise, France), E. coli K-12 strain BM14 8 and E. coli J53 reference strain were used in cloning and conjugation experiments. MICs were determined by Etest (bioMérieux) and were interpreted according to CLSI breakpoints. 15 The production of putative carbapenemases and ESBLs was evaluated using the Carba NP test and the ESBL NDP test, respectively, as previously described. 16 
PCR and sequencing
A PCR approach was used to detect different types of b-lactamase genes as previously described. 4 Cloning experiments were performed using XbaI restriction, a pBKCMV plasmid, expression in E. coli TOP10 and selection on trypticase soy agar supplemented with ticarcillin (50 mg/L) and kanamycin (30 mg/L). Plasmid DNAs were extracted using Qiagen columns (Qiagen) and sequenced on an ABI3130 sequencer (Applied Biosystems, Les Ulis, France). 4 PCR mapping of PGI1 was performed with primers chosen in the island backbone according to sequences available in the GenBank database (AF261825), and primers PGI1circ1 and PGI1circ2 were used for the detection of a circular extrachromosomal form of SGI1. 8 
SGI mobilization assays
Conjugal transfer was attempted by liquid and solid mating-out assays using a rifampicin-resistant E. coli J53 strain. Before mobilization experiments, plasmid R55 was introduced into P. mirabilis PEL donor by liquid conjugation with E. coli K-12 strain BM14 carrying R55 8 and selection on agar containing gentamicin (40 mg/L) and ceftazidime (2 mg/L). Mobilization of the circular form of PGI1 was attempted by liquid and solid mating-out assays with P. mirabilis PEL (pR55) as a donor and in vitro-selected rifampicin-resistant Salmonella enterica serovar Typhimurium LT2 as a recipient strain. Agar plates containing ceftazidime (2 mg/L) and rifampicin (200 mg/L) were used for selection of S. enterica transconjugants.
Nucleotide sequence accession number
The nucleotide sequence of the PGI1 variant from P. mirabilis PEL was submitted to GenBank under accession number KF856624.
Results and discussion
Susceptibility testing and carbapenemase identification P. mirabilis isolate PEL was resistant to amino-and carboxypenicillins, narrow-and broad-spectrum cephalosporins, moxalactam and aztreonam (Table S1 , available as Supplementary data at JAC Online). It was resistant to imipenem (MIC of 32 mg/L), but susceptible to meropenem and ertapenem (MICs of 0.75 and 0.25 mg/L, respectively; Table S1 ). The association of reduced susceptibility to imipenem with resistance to all b-lactams including broad-spectrum cephalosporins and cefoxitin was uncommon. PCR and sequencing identified the carbapenemase and ESBL genes bla NDM-1 and bla VEB-6 . In addition, P. mirabilis PEL was resistant to most of the non-b-lactam antibiotics, with the exception of gentamicin, fosfomycin and rifampicin (data not shown).
Genetic structures surrounding the bla NDM-1 gene
Plasmid pPEL-1, recovered after XbaI cloning experiments, possessed a 28.1 kb insert and haboured the bla NDM-1 gene bracketed by insertion sequence ISAba125 and the ble MBL gene encoding resistance to bleomycin, as previously identified in most bla NDM-1 -positive strains (Figure 1) . 18 The DNA fragment encompassing ISAba14, bla NDM-1 and ISCR1 (orf513) shared 99% nucleotide identity with a plasmid-borne fragment from Acinetobacter spp. M131 (accession number JX072963.1) (Figure 1 ). ISAba14 had been first identified to be associated with the class A b-lactamase gene bla CARB-14 in Acinetobacter baumannii 19 and also in NDM-1-producing A. baumannii isolates, but had not been reported from Enterobacteriaceae isolates to date. Although ISAba125 is systematically identified upstream of the bla NDM -like genes, 7 its role in the mobilization of this gene has not yet been demonstrated. In A. baumannii, it is likely that composite transposon Tn125 is at the origin of bla NDM gene acquisition, 20 while the ISCR1-like elements might be responsible for the mobilization of bla NDM in Enterobacteriaceae, through a rolling-circle transposition process or due to homologous recombination between two copies of ISCR1. 21 Noticeably, the bla NDM gene is the product of a gene fusion event, which has implications for its expression and subsequent mobility. 22 Genetic structure surrounding the bla VEB-6 gene
The close genetic environment of the bla VEB-6 gene shared 98% nucleotide identity with that previously reported on SGI1-V in a P. mirabilis isolate recovered in France in 2011. 9 However, SGI-V had a different backbone as compared with the novel PGI (named PGI-PmPEL) identified here ( Figure 1 ).
Genetic structure of the mer operon
Downstream of the bla NDM-1 -containing locus, a gene encoding a transposase of the Tn3 family was identified, showing 88% nucleotide identity with that of ISPa40. At the right-hand end of the complex integron, a region corresponding to the Tn501 mercury resistance module was identified, followed by the Tn5053 transposition module, containing four genes involved in transposition, i.e. tniA, tniB, tniQ and tniR. Sequencing of the 3 ′ -end of plasmid pPEL showed that the antibiotic resistance gene cluster was surrounded by inverted repeats IRt and DR-R of the SGI1 type ( Figure 1 ). 8 
Characterization of the PGI1 backbone
The 67 kb PGI1-PmPEL was integrated between the thdF and hipB/hipA chromosomal genes (Figure 1 ). The sequences of specific recombination sites (attP and attB sites) have been identified (Figure 1) . 8 The MDR region here interrupted the C1566 orf from Salmonella Heidelberg strain 7, suggesting that a large deletion had occurred from the res gene (C1584) to C1566 (Figure 1a) . The DR-R was located 109 bp downstream of orf C1564. This PGI1-PmPEL shared 99% identity with the two recently described PGI1-PmCHA and PGI1-PmCHE. Nevertheless, the same synteny was highly conserved between PGI1 and SGI1 backbones, suggesting that both islands belong to the same genomic island family.
Detection of an extrachromosomal form of PGI1
Most SGI1 have lost the ability of horizontal transfer. However, some integrative and conjugative elements (ICEs) can excise from the chromosome by a site-specific recombination, leading to the formation of circular extrachromosomal elements, which may be transferred by conjugation and integrated in a site-specific fashion into the recipient chromosome. 8 PCR experiments with PGI1circ1/2 primers confirmed the presence of a circular extrachromosomal form of PGI1-PmPEL in P. mirabilis PEL in the presence or absence of helper plasmid pR55. 8 
Conclusions
This study identified a new variant of PGI1 in a multiresistant P. mirabilis clinical isolate. This is the first known description of the bla NDM-1 gene, and more generally of a carbapenemaseencoding gene, in a resistance island element. Notably, the bla NDM-1 gene was associated with the ESBL gene bla VEB-6 in this same ICE, thus leading to a stable structure conferring a high level of resistance to all b-lactams, including aztreonam. The results obtained here indicate that resistance gene exchanges may occur between Acinetobacter spp. and P. mirabilis, as suggested by the occurrence of ISAba14 in P. mirabilis PEL. The likely scenario might be that Acinetobacter spp. may have been the first target of bla NDM-1 acquisition and then the structure was captured by Salmonella spp. to finally target in P. mirabilis or directly captured by a resident PGI in P. mirabilis. The latter may be the most probable, as bla NDM-1 has not been identified on SGI1-like structures in Salmonella spp. to date. This is an additional clue confirming the possible role of Acinetobacter spp. as a source of antibiotic resistance for enterobacterial species. In addition, our study showed that such a genetic structure harbouring several clinically relevant resistance genes might be stabilized through chromosomal integration and then be vertically transmitted without risk of plasmid loss.
Note added in proof
The recent results obtained by Siebor & Neuwirth (J Antimicrob Chemother 2014; 69: 3216 -3220) highlighted modifications in SGI nomenclature that led us to rename the ICE in our isolate of P. mirabilis as PGI1.
